Fascinating Proteinuria Therapeutics Market 2019-2023 Tactics That Can Help YourPosted by Ruchi Walt on November 26th, 2019 The global proteinuria therapeutics market is expected to grow at a CAGR of 2.50% during the forecast period. The major challenges affecting the growth of the global proteinuria therapeutics market include lack of curative therapies, adverse effects of available therapies, and stringent regulations.
The global proteinuria therapeutics market does not have any approved and curative therapies. The market is dominated by various off-label drugs for the treatment of the underlying condition. Also, drug development is an extensive process. Secondary conditions such as proteinuria, have multifactorial etiology, which complicates the process of drug development. Documentation related to the pathophysiology of the condition also becomes difficult, owing to the multifactorial etiology of proteinuria. Furthermore, drug manufacturers and researchers cannot recover their R&D expenses and generate profits. This is mainly because of the secondary nature of the condition, where the market already has drugs that treat the underlying cause of proteinuria. Such factors lead to an unfavorable environment for companies that focus on novel drug therapies is expected to hinder the growth of the market during the forecast period. However, despite the challenges, the global proteinuria therapeutics market is expected to grow in an accelerating momentum. Like it? Share it! More by this author |
